Vertical: CNMBase Year: 2025
Market Size (2025)
$672.15M
Projected (2032)
$1.31B
CAGR (2022–2032)
10.0%
Key Players
10+
Market Overview
The Global Plant Extract Biostimulants Market was valued at USD 672.15 Million in 2025 and is projected to reach USD 1,307.77 Million by 2032, expanding at a CAGR of 9.96% during the forecast period 2026–2032. The market has grown steadily from USD 503.33 Million in 2022, and the forecast implies an absolute addition of USD 635.61 Million between 2025 and 2032, meaning the market will nearly double in size over the period.
Plant extract biostimulants are formulations derived from seaweeds and terrestrial plants that, when applied to crops, seeds or the root zone, stimulate natural physiological processes to improve nutrient uptake and use efficiency, tolerance to abiotic stress such as drought, heat and salinity, and crop quality traits. Demand is being shaped by three structural forces: the need to raise yields and quality while reducing synthetic input intensity, the growing frequency of climate-related abiotic stress events, and the formal recognition of biostimulants as a distinct product category in regulatory frameworks such as the EU Fertilising Products Regulation (EU) 2019/1009, India's Fertiliser (Control) Order and Brazil's Bioinputs Law (Law No. 15,070 of 2024).
Key Findings
Raw Material Source: Seaweed Extracts formed the largest segment with USD 369.68 Million (55.0% share) in 2025, while Other Plant Extracts is the fastest-growing segment at a CAGR of 10.91%.
Physical Form: Liquid formulations led the market with USD 470.51 Million (70.0% share) in 2025 and are also the fastest-growing form at a CAGR of 10.35%.
Crop Type: Fruits & Vegetables accounted for the largest share at USD 369.68 Million (55.0%) in 2025, whereas Cereals & Grains is the fastest-growing crop type at a CAGR of 11.23%.
Region: Europe was the leading region with USD 248.70 Million (37.0% share) in 2025, while Asia Pacific is the fastest-growing region at a CAGR of 11.39%.
Country: The U.S. was the largest country market at USD 104.86 Million in 2025 (15.6% of the global market), and India is the fastest-growing country at a CAGR of 13.23%.
Segmentation Summary
By raw material source, seaweed extracts, principally derived from brown algae such as Ascophyllum nodosum, Ecklonia maxima and Sargassum species, remain the backbone of the market owing to their long commercial history, extensive field trial base and established supply chains. Other plant extracts, which include botanical extracts and plant-derived protein hydrolysates, are expanding faster (10.91% versus 9.14% for seaweed extracts) as suppliers commercialise targeted formulations with defined bioactive profiles. By physical form, liquid products dominate because of their compatibility with foliar spraying and fertigation systems, and their share is expected to rise further as drip irrigation and precision application spread. By crop type, fruits and vegetables account for the largest value given the high return per hectare on quality improvements, while cereals and grains represent the largest untapped area opportunity and are growing at 11.23%.
Competitive Landscape Summary
The market is moderately fragmented. A group of established seaweed extract specialists and diversified agricultural input companies holds a leading position, alongside a long tail of regional formulators. Leading participants include Acadian Plant Health (Acadian Seaplants), Syngenta Biologicals (Valagro), Biolchim Group (J.M. Huber Corporation), Rovensa Next (Tradecorp), UPL (Natural Plant Protection and Laboratoires Goëmar), Kelp Products International (Kelpak), Beijing Leili Marine Bioindustry, Hello Nature, BioAtlantis and Biostadt India. Since 2022 the competitive landscape has been reshaped by consolidation, including J.M. Huber's acquisition of Biolchim, Rovensa's acquisition of Agro-K, and Syngenta's integration of Valagro into Syngenta Biologicals. It has also been reshaped by distribution alliances such as the 2024 agreement bringing Acadian Plant Health's seaweed biostimulants into the BASF BioSolutions portfolio, and by investments in new production capacity in North America.
Challenges and Opportunities
The principal challenges include variability in field efficacy across soils, climates and crops; the cost of generating the agronomic evidence now required for registration under new regulatory frameworks; seasonal and environmental pressure on wild seaweed harvests; and the absence of a harmonised federal definition of plant biostimulants in the United States. Opportunities centre on the extension of biostimulant use from high-value horticulture into broadacre cereals and grains, the integration of plant extracts into seed treatments and combination products with nutrients or microbials, the growth of cultivated seaweed as a more secure raw material base, and rapid adoption in Asia Pacific, Latin America and the Middle East & Africa, all of which are forecast to grow faster than the global average.
Future Outlook
Over 2026–2032 the market is expected to benefit from tighter nutrient-use regulations, the push to lower the carbon footprint of crop production, and the growing evidence base linking plant extract biostimulants to abiotic stress mitigation. Europe will remain the largest regional market, rising from USD 248.70 Million in 2025 to USD 433.52 Million in 2032, although its share will gradually decline as Asia Pacific (11.39%), Middle East & Africa (11.02%) and Latin America (10.96%) grow faster. Competitive advantage will increasingly depend on proprietary extraction technology, documented modes of action, regulatory registrations across multiple jurisdictions and access to global distribution networks.
The Plant Extract Biostimulants Market market is projected to grow at a CAGR of 10.0% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Plant extract biostimulants are non-microbial products obtained from marine macroalgae (seaweeds) or terrestrial plants that, when applied to plants, seeds or the rhizosphere, stimulate natural plant processes independently of their nutrient content. Their function is to improve one or more of the following: nutrient use efficiency, tolerance to abiotic stress, crop quality traits, and the availability of confined nutrients in the soil or rhizosphere. This functional definition is consistent with the definition of a plant biostimulant used in the EU Fertilising Products Regulation (EU) 2019/1009, under which seaweed and botanical extracts fall within the non-microbial plant biostimulant category.
Seaweed extracts are produced from brown algae such as Ascophyllum nodosum, Ecklonia maxima, Laminaria and Sargassum species through alkaline, acid, enzymatic, fermentation or mechanical (cell-burst and low-temperature) extraction. They contain polysaccharides such as alginates, laminarins and fucoidans, together with polyphenols, betaines and naturally occurring phytohormone-like compounds. Other plant extracts include extracts from terrestrial plants, such as botanical extracts rich in polyphenols, flavonoids or saponins, and plant-derived protein hydrolysates and amino acid preparations obtained from legume or other vegetable biomass.
Included in the scope: seaweed extracts and other plant-derived extracts marketed for agricultural use as biostimulants, supplied in liquid (solutions, suspensions, concentrates) or dry (powders, soluble crystals, granules and microgranules) form and applied by foliar spray, fertigation, soil drench, seed treatment or post-harvest dip on fruits and vegetables, cereals and grains and other crops.
Excluded from the scope: microbial biostimulants (for example, mycorrhizal fungi, Azotobacter and Rhizobium inoculants); humic and fulvic substances of mineral origin; animal-derived protein hydrolysates; chitosan and other non-plant biopolymers; botanical biopesticides registered primarily for pest or disease control; synthetic plant growth regulators; and seaweed products sold for food, feed, cosmetic or pharmaceutical uses.
Scope of the Study
The study quantifies the global market for plant extract biostimulants in value terms (USD Million) for the historic years 2022, 2023 and 2024, the base year 2025 and the forecast years 2026–2032. Growth rates are presented as compound annual growth rates for 2026–2032. The market is analysed according to the following segmentations:
By Raw Material Source: Seaweed Extracts; Other Plant Extracts
By Physical Form: Liquid; Dry
By Crop Type: Fruits & Vegetables; Cereals & Grains; Others
By Region: North America (U.S., Canada, Mexico); Europe (Germany, U.K., France, Italy, Spain, Rest of Europe); Asia Pacific (China, India, Japan, Rest of Asia Pacific); Latin America (Brazil, Argentina, Rest of Latin America); Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA)
Research Objectives
To estimate and forecast the size of the global plant extract biostimulants market in value terms (USD Million) for 2022–2032.
To analyse the market by raw material source, distinguishing the established seaweed extract segment from the faster-growing other plant extracts segment.
To assess the market by physical form and by crop type, and to identify where liquid and dry formulations and specific crop groups create the greatest value.
To quantify regional and country-level demand across North America, Europe, Asia Pacific, Latin America and the Middle East & Africa.
To identify the drivers, restraints, opportunities, trends and challenges shaping adoption, including regulatory developments in the EU, United States, India, Brazil and Canada.
To evaluate the value chain from seaweed harvesting and plant biomass sourcing through extraction, formulation and distribution to growers.
To assess the competitive environment, including the positioning of leading suppliers and key developments such as acquisitions, partnerships, capacity expansions and product launches since 2022.
To provide a forward-looking view of growth opportunities for manufacturers, distributors and investors over 2026–2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured, multi-stage research process. It began with a definition of the market boundary and segmentation, followed by extensive secondary research to build a baseline understanding of supply, demand, pricing and regulation. Primary research with participants across the value chain was then used to validate and refine the findings. Market size was estimated using both top-down and bottom-up approaches, and the results were reconciled through data triangulation. The forecast was developed by modelling the influence of demand-side, supply-side, regulatory and macroeconomic factors on each segment, region and country, and the final figures were subjected to internal consistency checks.
Secondary Research
Secondary research drew on sources specific to agricultural inputs and the biostimulants industry, including:
Industry associations: the European Biostimulants Industry Council (EBIC), the Biological Products Industry Alliance (BPIA) in the United States, the Biostimulant Manufacturers Association of India and national fertiliser and crop protection associations, for market commentary, position papers and regulatory updates.
Government and regulatory bodies: the European Commission and EUR-Lex (Regulation (EU) 2019/1009), the U.S. Environmental Protection Agency and U.S. Department of Agriculture, the Canadian Food Inspection Agency, India's Ministry of Agriculture & Farmers Welfare (Fertiliser (Control) Order), Brazil's Ministry of Agriculture and Livestock (MAPA) and national agricultural statistics offices for crop area, production and input-use data.
Intergovernmental organisations: the Food and Agriculture Organization (FAO) for crop production statistics and global seaweed production and harvesting data.
Company filings and disclosures: annual reports, investor presentations, press releases and product literature of seaweed extract manufacturers, biostimulant formulators and diversified crop input companies.
Trade and scientific journals: agribusiness trade publications, horticulture and crop science journals, and peer-reviewed literature on the modes of action and field efficacy of seaweed and botanical extracts.
Paid databases: company databases, trade statistics and agricultural market intelligence services for financial, trade-flow and crop-economics data.
Primary Research
Primary research was conducted through in-depth telephone and online interviews to validate secondary findings, fill information gaps and obtain forward-looking insight. The approach covered both the supply side and the demand side of the market.
Supply side: executives, product managers and technical specialists at seaweed harvesting and processing companies, plant extract manufacturers, biostimulant formulators, contract manufacturers and agricultural input distributors.
Demand side: commercial growers of fruits, vegetables and field crops, agronomists and crop consultants, greenhouse and protected-cultivation operators, cooperatives, and procurement staff at agricultural retail outlets.
Other participants: regulatory consultants, academic researchers and industry association representatives.
The objectives of primary research were to validate the segmentation and market size estimates, understand pricing and margins across the value chain, assess adoption drivers and barriers by crop and region, and gather qualitative input on competitive positioning and future product and technology trends.
Market Size Estimation
Top-down approach: The overall biostimulants market was first established from industry and company data, and the share attributable to plant extract biostimulants was derived. This value was then apportioned to raw material source, physical form, crop type, region and country using shares obtained from secondary research and validated through primary interviews.
Bottom-up approach: Country-level demand was built from treated crop area, application rates per hectare, number of applications per season and average product prices for each crop group and physical form. Revenue estimates for leading manufacturers in the plant extract biostimulants business were aggregated as a further cross-check of supply-side value.
Data triangulation: The top-down and bottom-up estimates were compared, and differences were reconciled using primary research inputs and supply-side checks. This process ensured that the segment, regional and country estimates were consistent with each other and with the overall market total.
Forecasting Methodology
The forecast was developed by projecting the base-year (2025) estimates for each segment and geography over 2026–2032. It considered the following factors:
Growth in harvested area and the value of fruit, vegetable and field crop production by country.
Penetration rates of biostimulants by crop group and the expected rate of adoption among commercial growers.
Regulatory developments affecting product registration, labelling claims and market access.
Pricing trends, raw material availability and extraction capacity additions.
Macroeconomic indicators, farm income trends and the incidence of climate-related abiotic stress.
Competitive activity, including new product launches, partnerships and distribution agreements.
Growth rates were applied at segment and country level and aggregated to regional and global totals. The results were reviewed against historic growth patterns and expert opinion to ensure plausibility.
Assumptions and Limitations
Values are expressed in nominal USD Million. Local-currency data were converted at average annual exchange rates, and currency fluctuations may affect comparisons between years.
The study assumes no major disruption to global agricultural trade or to seaweed harvesting and processing capacity during the forecast period.
Regulatory frameworks in force or announced at the time of the study are assumed to be implemented broadly as planned, including the Fertiliser (Control) Order requirements in India and the Bioinputs Law in Brazil.
Product classification differs between jurisdictions. Some products sold as fertilisers containing plant extracts in certain countries have been allocated to this market where plant extracts are the primary functional component.
Private companies do not publish segment revenues, so supply-side estimates for these companies rely on primary research and analyst assessment.
The forecasts reflect currently available information. Unforeseen weather events, commodity price movements or policy changes could cause actual results to differ.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global plant extract biostimulants market is moderately fragmented. A group of established seaweed extract specialists and diversified crop input companies with global distribution holds a leading position. Alongside them are a large number of regional manufacturers, formulators and private-label suppliers, particularly in Europe, China and India. Competition is based on the efficacy and consistency of products, proprietary extraction technology, secure access to raw materials, regulatory registrations across jurisdictions, agronomic support and distribution reach.
The competitive structure has changed significantly since 2022. Large agricultural and specialty chemical companies have expanded their presence through acquisitions, such as J.M. Huber Corporation's acquisition of the Biolchim Group and Rovensa's acquisition of Agro-K, and through organisational integration, notably the combination of Valagro with Syngenta's other biological businesses to form Syngenta Biologicals. Specialist manufacturers are increasingly partnering with multinational distributors, as shown by the 2024 agreement under which Acadian Plant Health's seaweed biostimulants joined BASF's BioSolutions portfolio. New regulatory requirements, including CE marking under the EU Fertilising Products Regulation and Schedule VI registration under India's Fertiliser (Control) Order, are raising the evidence and compliance bar. This is expected to favour well-resourced suppliers and accelerate consolidation over the forecast period.
Key Player Positioning
Leaders: Acadian Plant Health, Syngenta Biologicals (Valagro) and Rovensa Next (Tradecorp) are positioned as market leaders. Acadian Plant Health, the plant health division of privately held Acadian Seaplants of Nova Scotia, Canada, is one of the largest Ascophyllum nodosum processors and sells in more than 80 countries. Syngenta Biologicals combines Valagro's biostimulant portfolio and manufacturing base with the global reach of Syngenta Group, which reported sales of USD 28,400 Million in fiscal year 2025. Rovensa Next, the biosolutions unit of Rovensa, offers Ascophyllum-based extracts such as Phylgreen, produced at Tradecorp's facility in Ireland, together with a broad bionutrition portfolio across more than 90 countries.
Challengers: Biolchim Group (owned by J.M. Huber Corporation, which reports annual revenue of approximately USD 2,500 Million) and UPL, through its Natural Plant Protection (NPP) unit and Laboratoires Goëmar in Saint-Malo, France, are strong challengers with growing biostimulant portfolios and wide distribution. UPL reported revenue of INR 51,839 crore for fiscal year 2026 (April 2025–March 2026). Kelp Products International (Kelpak) and Beijing Leili Marine Bioindustry are established seaweed extract specialists with wide international distribution, based on Ecklonia maxima and Sargassum respectively.
Niche players: Hello Nature (plant-based biostimulants and organic nutrition, with expanding production in the United States), BioAtlantis (Ireland, research-led Ascophyllum bioactives for stress tolerance) and Biostadt India (a pioneer of seaweed-based biostimulants in India) occupy focused positions defined by technology, crop specialisation or geography. Most of the specialist companies are privately held and do not publicly disclose revenue.
Competitor Dashboard
The dashboard below provides a qualitative assessment of the profiled companies on four competitive parameters.
Threat of New Entrants – Medium
Basic seaweed extraction technology is widely available and capital requirements for small-scale formulation are modest, which allows regional players to enter.
New regulatory regimes requiring efficacy data, quality controls and registration dossiers (EU FPR, India FCO) are raising entry barriers for credible product claims.
Established players benefit from secure raw material access, proprietary extraction processes and long-standing distributor relationships.
Bargaining Power of Suppliers – Medium
Wild seaweed harvesting is concentrated in specific coastlines and subject to quotas, giving harvesters some leverage over non-integrated processors.
Many leading manufacturers are vertically integrated into harvesting or have long-term supply contracts, which reduces supplier power.
Terrestrial plant biomass and processing chemicals are widely available from multiple sources.
Bargaining Power of Buyers – Medium
Large distributors and crop input companies buy in volume and can negotiate prices or source private-label products.
Individual growers are fragmented and have limited bargaining power, but they can easily switch between brands when efficacy is not demonstrated.
Differentiated products with documented claims and agronomic support reduce price sensitivity.
Threat of Substitutes – Medium
Microbial biostimulants, humic and fulvic substances, animal-derived protein hydrolysates and enhanced-efficiency fertilisers compete for the same budget for nutrient efficiency and stress tolerance.
Synthetic plant growth regulators can deliver some similar effects in specific crops.
The broad multi-functional effects and natural origin of plant extracts limit direct substitution, particularly in organic and residue-sensitive production.
Intensity of Competitive Rivalry – High
The market contains a large number of global, regional and local suppliers, many offering similar seaweed-based products.
Competition is intensifying as multinational crop input companies enter through acquisitions and partnerships.
Rivals compete on efficacy evidence, extraction technology, regulatory approvals, price and distribution reach.
Threat of New Entrants: Medium; Low technical barriers offset by rising regulatory and evidence requirements.
Bargaining Power of Suppliers: Medium; Concentrated wild seaweed supply partly offset by vertical integration.
Bargaining Power of Buyers: Medium; Large distributors negotiate strongly; growers are fragmented.
Threat of Substitutes: Medium; Microbials, humic substances and enhanced-efficiency fertilisers compete for budget.
Intensity of Competitive Rivalry: High; Many suppliers with similar products and active consolidation.
Market estimates by geography (2032)
InsightEurope leads with $433.52M by 2032, while Asia Pacific is projected to grow fastest at a 11.5% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $99.91M | $163.63M | $266.13M | 10.3% | 20% |
| Europe | $194.54M | $292.25M | $433.52M | 8.3% | 33% |
| Asia Pacific | $106.20M | $183.98M | $315.17M | 11.5% | 24% |
| Latin America | $78.27M | $132.69M | $222.97M | 11.0% | 17% |
| Middle East & Africa | $24.41M | $41.52M | $69.97M | 11.1% | 5% |
| Total | $503.33M | $814.06M | $1.31B | 10.0% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$1.31B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Seaweed Extracts | $682.65M | 9.2% | 52% |
| Other Plant Extracts | $625.11M | 11.0% | 48% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Plant Extract Biostimulants Market covering market dynamics, competitive landscape, and strategic outlook.
The Plant Extract Biostimulants Market market is projected to reach $1.31B by 2032, growing at 10.0% CAGR. The Seaweed Extracts segment holds the largest share.
The Global Plant Extract Biostimulants Market is being shaped by a combination of macroeconomic, regulatory, agronomic and commercial forces. Growers are under pressure to protect yields and crop quality while using fertilisers more efficiently, and climate variability is increasing the frequency of drought, heat and salinity stress. Regulators in several major agricultural economies have formally recognised plant biostimulants as a product category, while input companies are investing in biologicals as a strategic growth area. At the same time, the market faces constraints relating to efficacy variability, evidence requirements, raw material supply and grower awareness. This chapter assesses these factors. The impact scores in the growth factor analysis below are analyst assessments, based on secondary and primary research, of the relative strength of each factor's effect on market growth in each period, on a scale of 1 (minimal) to 10 (very strong).
Rising Incidence of Abiotic Stress Linked to Climate Change
Drought, heat waves, temperature extremes and soil salinisation are increasingly cutting yields across major growing regions, and conventional nutrition and crop protection programmes do little to address them directly. Abiotic stress mitigation is where seaweed extracts have the deepest body of evidence. Extracts of Ascophyllum nodosum and Ecklonia maxima contain osmoprotectants, antioxidant compounds and signalling molecules that help plants maintain cell turgor, root growth and photosynthetic activity under stress. Suppliers are positioning their products explicitly around this benefit. Acadian Plant Health has stated an ambition to become the leading crop abiotic stress management company with seaweed as its core technology, and in 2025 it launched a seaweed-based seed treatment targeting early-season stress. Rovensa Next's Ascophyllum-based Phylgreen obtained CE marking under the EU Fertilising Products Regulation in 2024 with a claim related to drought stress. As growers increasingly treat climate risk as recurring rather than exceptional, stress-management programmes are moving from occasional rescue applications to scheduled preventive use. This raises the number of applications per season and supports volume growth across fruits, vegetables and field crops.
Policy Pressure to Improve Nutrient Use Efficiency and Reduce Chemical Inputs
Governments are tightening the rules on fertiliser and pesticide use to reduce nutrient losses, greenhouse gas emissions and water pollution. In the European Union, the Farm to Fork Strategy set a target of reducing nutrient losses by at least 50% and fertiliser use by at least 20% by 2030. Member states also enforce nitrate rules under the Nitrates Directive and national fertiliser ordinances. China launched an action plan for zero growth in chemical fertiliser use in 2015. Japan's Strategy for Sustainable Food Systems (MIDORI) targets a 30% reduction in chemical fertiliser use by 2050, and India actively promotes balanced fertilisation and natural farming. Plant extract biostimulants are well positioned under these policies because they can improve nutrient uptake and use efficiency, allowing growers to maintain yields at lower nutrient rates. Fertiliser price spikes in 2022 further encouraged growers to look at products that make each unit of nutrient go further. As compliance pressure and sustainability reporting by food companies and retailers intensify, input suppliers increasingly bundle biostimulants into nutrient-efficiency programmes. This structurally lifts demand across both horticultural and broadacre crops.
Regulatory Recognition Creating a Defined Product Category
For many years plant extract biostimulants were sold under fertiliser, soil amendment or growth regulator rules that differed widely by country, which limited the claims suppliers could make and created uncertainty for buyers. That situation is changing. Regulation (EU) 2019/1009, applicable since July 2022, introduced plant biostimulants as a product function category with a CE-marking route that gives access to the entire single market. India amended the Fertiliser (Control) Order in February 2021 to bring biostimulants, including botanical and seaweed extracts, under a formal registration regime, and provisional registrations ended in June 2025. Brazil enacted Law No. 15,070 in December 2024, establishing a dedicated legal framework for bioinputs, including biostimulants. Canada completed a three-year transition to its modernised Fertilizers Regulations in October 2023. In the United States, the Plant Biostimulant Act of 2025 was introduced in both chambers of Congress. Clearer rules raise the bar for evidence but also give compliant products credible, harmonised claims, encourage investment and remove low-quality products from the market. Over the medium term this supports market growth.
Growth of High-Value Horticulture and Protected Cultivation
Fruits, vegetables, vineyards, orchards and greenhouse crops generate high revenue per hectare. In these crops improvements in fruit set, size, colour, firmness, sugar content and shelf life translate directly into higher grower income, so the return on a biostimulant programme is easiest to demonstrate there. Export-oriented horticulture in Spain, Italy, Mexico, Chile, Peru, Morocco and South Africa has to meet demanding quality and residue standards set by retailers, which favours biological input programmes. Investment in protected cultivation and controlled-environment agriculture, including large greenhouse projects in the Middle East, Mexico and Asia, is adding acreage where fertigation-compatible liquid extracts are applied repeatedly through the season. The expansion of drip irrigation and precision spraying also makes it easier to integrate biostimulants into existing nutrient programmes without additional field passes. Together, these trends sustain demand from the fruits and vegetables segment, the largest crop type in the market.
Expansion into Cereals, Grains and Broadacre Crops
Cereals, grains and oilseeds occupy the largest share of global cropland, yet biostimulant penetration in these crops remains low compared with horticulture. The cereals & grains segment is the fastest-growing crop type in this market, at a CAGR of 11.23%. Cost-effective seed treatments, low-dose foliar products that can be tank-mixed with existing crop protection sprays, and formulations targeting nitrogen use efficiency and early-season stress can unlock very large treatable areas in the United States, Brazil, Argentina, India and Europe.
Seed Treatments, Combination Products and Biological Programmes
Suppliers are integrating plant extracts into seed treatments, microgranules and combination products that pair extracts with nutrients, microbials or crop protection active ingredients. Recent examples include Acadian Plant Health's seaweed-based seed treatment launched in 2025 and the inclusion of seaweed biostimulants in BASF's BioSolutions portfolio. Such integrated programmes improve convenience for growers, broaden application windows and allow larger crop input companies to sell plant extracts through their established channels.
Cultivated Seaweed and Advanced Extraction Technologies
Growth in seaweed aquaculture, particularly in Asia, together with investment in new extraction processes such as low-temperature, enzymatic and fermentation-based methods, offers a route to more secure and consistent raw material and to extracts with better-characterised bioactive profiles. Companies that can document their mode of action at the molecular level and guarantee batch-to-batch consistency will be better placed to secure regulatory approvals, command premium pricing and penetrate markets where the evidence bar is rising.
Variability in Field Efficacy and Evidence Requirements
The response of crops to plant extract biostimulants depends on the extract source, extraction process, dose, timing, crop, soil and weather conditions. As a result, field trial results can be inconsistent and some growers remain sceptical about the return on investment. Regulatory frameworks such as the EU FPR and India's FCO now require registrants to substantiate the claimed effects with agronomic data. Smaller manufacturers find it costly to generate multi-season, multi-location trial data, which slows product registration and limits the breadth of claims they can make.
Raw Material Supply Constraints and Price Volatility
Seaweed extract production depends heavily on wild-harvested brown algae such as Ascophyllum nodosum in the North Atlantic, Ecklonia maxima in southern Africa and Sargassum in Asia. Harvest volumes are subject to regulatory quotas, ecological sustainability requirements, weather and seasonal variation. Competing demand from food, hydrocolloid, feed and cosmetic uses can also tighten supply. These factors create cost pressure and supply risk for manufacturers, particularly those without integrated harvesting operations.
Fragmented Regulation and the Absence of a U.S. Federal Definition
Despite progress in several regions, biostimulant regulation remains fragmented. In the United States there is no statutory federal definition of a plant biostimulant. Products are registered under state fertiliser laws, and claims that overlap with plant growth regulation can trigger pesticide registration requirements under federal law. Differences in definitions, data requirements and labelling rules between jurisdictions raise compliance costs for companies selling internationally and delay market entry for new products.
Challenge: Grower Education and Proof of Return on Investment
Many growers, particularly in broadacre and smallholder systems, still have limited familiarity with how biostimulants work and when to apply them. Building adoption requires sustained investment in demonstration trials, agronomic advisory services and digital decision-support tools that link application timing to crop stage and weather. Suppliers that can show a consistent return on investment in the grower's own conditions will capture a disproportionate share of growth.
Trend: Consolidation and Strategic Partnerships
Large crop input companies regard biologicals as a strategic growth area and are acquiring or partnering with specialist biostimulant manufacturers. Examples include J.M. Huber Corporation's acquisition of the Biolchim Group (completed November 2022), the combination of Valagro with Syngenta's in-house biologicals into Syngenta Biologicals (July 2023), and Rovensa's acquisition of Agro-K (November 2023). This trend is expected to continue as companies seek proprietary technology and regional market access.
Trend: Science-Led Product Differentiation
Suppliers are shifting from generic "seaweed extract" positioning to products defined by extraction process, bioactive composition and a specific agronomic claim, such as drought tolerance, fruit set or nutrient use efficiency. Proprietary processes, for example Acadian Plant Health's BioSwitch process introduced in 2023 and Rovensa Next's low-temperature extraction used for Phylgreen, are being used to justify differentiated claims under the new regulatory regimes.
Trend: Investment in Regional Manufacturing Capacity
To shorten supply chains and serve growing demand in the Americas, companies are investing in local production. Syngenta Biologicals formally opened a biostimulant production facility in Orangeburg, South Carolina in 2025, and Hello Nature announced a large plant-based nutrition facility in Wabash, Indiana in December 2024. Regional manufacturing improves service levels and reduces logistics costs for liquid formulations.
The value chain of the plant extract biostimulants market comprises four principal stages: raw material sourcing, extraction and formulation, distribution, and end use.
Raw materials and inputs: Brown seaweeds (Ascophyllum nodosum, Ecklonia maxima, Laminaria and Sargassum species) are harvested from wild stocks or cultivated, while terrestrial plant biomass, botanical raw materials and legume-derived proteins are sourced from agricultural and agro-industrial supply chains. Other inputs include water, alkalis, acids or enzymes for extraction, and formulation aids such as stabilisers, preservatives and co-formulants. Access to sustainable, traceable raw material is a key source of competitive advantage, and several leading suppliers operate integrated harvesting and processing.
Manufacturing (extraction and formulation): Raw material is washed, milled and extracted using alkaline hydrolysis, acid or enzymatic hydrolysis, fermentation, or mechanical and low-temperature processes. Extracts are then concentrated, filtered and either stabilised as liquids or dried into powders, soluble crystals or granules. Formulators may combine extracts with nutrients, amino acids or other biostimulant ingredients. Quality control, consistency of bioactive content and regulatory dossiers are essential at this stage.
Distribution and channels: Products reach the market through multinational crop input companies, specialist biostimulant companies, national and regional agricultural distributors, cooperatives, agro-dealers and retail outlets, and increasingly through online channels. Private-label supply and toll manufacturing for larger brands are common, and distribution partnerships give specialist manufacturers access to wider geographic markets.
End users: Commercial growers of fruits and vegetables, vineyards and orchards, greenhouse and protected-cultivation operators, row-crop and cereal farmers, turf and ornamental managers, and smallholder farmers. Agronomists, crop consultants and retailers strongly influence purchasing decisions and application practice.
Europe
Regulation (EU) 2019/1009 (the EU Fertilising Products Regulation), adopted on 5 June 2019 and applicable from 16 July 2022, established "plant biostimulant" as a product function category (PFC 6), divided into microbial and non-microbial plant biostimulants. Seaweed and botanical extracts fall within the non-microbial category. Products that meet the requirements can carry CE marking and circulate freely within the EU single market following conformity assessment. Harmonisation is optional, however, so products may continue to be sold under national fertiliser legislation subject to mutual recognition. Italy's Legislative Decree 75/2010 and Spain's Royal Decree 506/2013 on fertiliser products are examples of national frameworks that pre-date the EU regulation.
North America
In the United States, there is currently no statutory federal definition of a plant biostimulant. Most plant extract products are registered as fertilisers, soil amendments or beneficial substances under state laws. The U.S. Environmental Protection Agency has issued draft guidance (2019, updated in November 2020) on plant regulator claims, including plant biostimulants, which clarifies when claims would trigger registration under the Federal Insecticide, Fungicide, and Rodenticide Act. The Plant Biostimulant Act of 2025 was introduced in the Senate (S.1907) and the House of Representatives (H.R.3783) to establish a federal definition. In Canada, products are regulated by the Canadian Food Inspection Agency under the Fertilizers Act and Fertilizers Regulations. The modernised regulations became fully mandatory after a three-year transition period ended on 26 October 2023.
Asia Pacific
India brought biostimulants under the Fertiliser (Control) Order, 1985 through a notification dated 23 February 2021. The order defines categories that include botanical extracts and seaweed extracts and requires products to be registered against specifications listed in Schedule VI. A simplified procedure was notified in May 2024, and provisional registrations ended in June 2025, after which only products listed in Schedule VI may be sold. In China, plant extract and seaweed-based products are generally registered as fertiliser products with the Ministry of Agriculture and Rural Affairs (MARA) under the national fertiliser registration system.
Latin America
Brazil enacted Law No. 15,070 on 23 December 2024, creating a dedicated legal framework for the production, registration, commercialisation and use of bioinputs, including biostimulants, biofertilisers and inoculants, and covering on-farm production. The law builds on the National Bioinputs Program run by the Ministry of Agriculture and Livestock (MAPA), whose strategic council was established by Decree No. 10,375 of 26 May 2020.
Middle East & Africa
In most Middle East and African markets, plant extract biostimulants are registered under national fertiliser or agricultural input regulations administered by ministries of agriculture. In South Africa, registration is required under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act No. 36 of 1947). Gulf Cooperation Council states require registration of fertilisers and agricultural inputs with national authorities before import and sale.
May 2022: UPL (NPP); Partnership; NPP partnered with Kimitec's MAAVi Innovation Center to commercialise five biostimulant and nutrition products in the United States.
Aug 2022: J.M. Huber Corporation; Acquisition; Signed an agreement to acquire the Biolchim Group, an Italy-based biostimulant and specialty plant nutrition company.
Sep 2022: Acadian Plant Health; Regulatory approval; Among the first biostimulant companies to obtain approval for Ascophyllum nodosum-based formulations under the EU Fertilising Products Regulation (EU) 2019/1009.
Nov 2022: J.M. Huber Corporation; Acquisition; Completed the acquisition of the Biolchim Group, including Cifo, Ilsa, Matécsa and West Coast Marine-Bio Processing.
Jan 2023: UPL; Product launch; Launched WAVE, a seaweed extract biostimulant, in Canada following registration with the Canadian Food Inspection Agency.
Feb 2023: Rovensa; Business expansion; Launched Rovensa Next, a dedicated biosolutions business unit bringing together Tradecorp and other biological companies.
Jun 2023: Acadian Plant Health; Partnership; Joined the Global Seaweed Coalition, supporting the sustainable development of the seaweed sector.
Jul 2023: Syngenta Group; Business integration; Combined Valagro and Syngenta's in-house biologicals business to form Syngenta Biologicals.
Nov 2023: Rovensa; Acquisition; Acquired Agro-K, a U.S.-based biostimulant and plant nutrition company, strengthening its presence in North America.
Dec 2023: Acadian Plant Health; Technology launch; Introduced BioSwitch, a proprietary seaweed extraction process.
Sep 2024: Rovensa Next; Regulatory approval; Phylgreen, an Ascophyllum nodosum-based biostimulant, obtained CE marking under the EU Fertilising Products Regulation as a non-microbial plant biostimulant.
Oct 2024: Acadian Plant Health / BASF; Partnership; Distribution agreement adding Acadian Plant Health's seaweed-based biostimulants to BASF's BioSolutions portfolio in several European countries and China.
Dec 2024: Syngenta Biologicals; Acquisition; Acquired Intrinsyx Bio, a developer of biologicals for nutrient use efficiency.
Dec 2024: Hello Nature; Expansion; Announced a USD 50 Million plant-based nutrition manufacturing facility in Wabash, Indiana, in a joint venture with MPS Egg Farms.
May 2025: Acadian Plant Health; Product launch; Launched a seaweed-based biostimulant seed treatment for abiotic stress management.
May 2025: Syngenta Biologicals; Expansion; Formally opened its biostimulant manufacturing facility in Orangeburg, South Carolina, United States.
Jun 2026: Rovensa Next / Novonesis; Partnership; Agreement for Rovensa Next to distribute Novonesis biosolutions in the United States from the 2027 season.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 107 companies operating in the Plant Extract Biostimulants Market market, including revenue, employee count, and market positioning where available.
Showing 107 of 107 companies
4 interactive charts drawn from the Plant Extract Biostimulants Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Plant Extract Biostimulants Market By Crop Type
Global Plant Extract Biostimulants Market By Physical Form
Global Plant Extract Biostimulants Market By Raw Material Source
Global Plant Extract Biostimulants Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
